Read time 1 minute | Tuesday, 1 April 2025
Print Friendly, PDF & Email
As the world’s population ages, neurodegenerative conditions like Alzheimer’s disease are becoming more and more common. Alzheimer’s is the leading cause of dementia. And though research into these conditions has yielded many fascinating results, few have translated to clinical applications. Today, we have a better idea of what Alzheimer’s does to the brain. However, we’re still a long way from figuring out how to cure the disease or prevent it from taking hold in the first place. Rooting out these mysteries requires a bold, new approach.
Recognizing this, the Pershing Square Foundation has awarded Cold Spring Harbor Laboratory Associate Professor Lucas Cheadle the 2025 MIND Prize. The annual award provides neuroscientists with $750,000 over three years. It is meant to empower early-career scientists to put themselves in a different frame of mind so they can look at neurodegenerative diseases like never before. That’s exactly what Cheadle is doing.
“Rather than focus solely on well-studied brain cells like microglia, our lab is investigating the much lesser-known oligodendrocyte precursor cells (OPCs),” Cheadle says. “Our hope is that looking at these early-forming brain cells and how they interact with synapses will offer an earlier window into Alzheimer’s disease.” And that new view could point to therapeutic or preventive strategies that haven’t yet been considered.
“I want to express my appreciation for the Pershing Square Foundation’s ongoing support as they also provided funding earlier in my career through the Innovation Fund,” Cheadle adds. “That early funding helped us get where we are today. So, having the opportunity to work with Pershing Square on another ambitious project is very satisfying. And I feel very grateful to the Foundation for seeing the value in our work.”
Written by: Samuel Diamond, Editorial Content Manager | diamond@cshl.edu | 516-367-5055
Stay informed
Sign up for our newsletter to get the latest discoveries, upcoming events, videos, podcasts, and a news roundup delivered straight to your inbox every month.
Newsletter Signup